M

Marksans Pharma
MARKSANS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
₹117.48B
EV
₹113.88B
Shares Outstanding
453.16M
Beta
1.38

Wall Street View

Analyst Rating
BUY
Analyst Target Price
₹301.00
P/E 2026E
24.12x
P/Revenue 2026E
3.73x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Marksans Pharma Limited

gainify

M

Marksans Pharma Limited

MARKSANS

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The compan...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Saldanha, Mark

Employees

1,141

IPO Date

2002-07-19

Headquarters

Grandeur, 11th Floor, Veera Desai Extension Road, Oshiwara, Andheri (West), Mumbai, Maharashtra, 400053, India

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.